GSE108464 AZ-628 6 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE108464_AZ-628_6_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE108464_AZ-628_6_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE108464_AZ-628_6_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE108464_AZ-628_6_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

MIR4435-2 host gene

Gene

uncharacterized LOC645485

Gene

RNA component of 7SK nuclear ribonucleoprotein

Gene

long intergenic non-protein coding RNA 559

Gene

ribosomal protein L7a pseudogene 7

Gene

EIF3E pseudogene 2

Gene

X-ray repair cross complementing 6 pseudogene 5

Gene

gem nuclear organelle associated protein 5

Gene

interferon regulatory factor 2 binding protein like

Gene

chromosome 3 open reading frame 80


  • Gene

    uncharacterized LOC645485


  • Gene

    RNA component of 7SK nuclear ribonucleoprotein


  • Gene

    long intergenic non-protein coding RNA 559


  • Gene

    ribosomal protein L7a pseudogene 7


  • Gene

    EIF3E pseudogene 2


  • Gene

    X-ray repair cross complementing 6 pseudogene 5


  • Gene

    gem nuclear organelle associated protein 5


  • Gene

    interferon regulatory factor 2 binding protein like


  • Gene

    chromosome 3 open reading frame 80

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.